Dichotomy Between U.S. Tobacco Export Policy and Antismoking Initiatives
T-NSIAD-90-42: Published: May 17, 1990. Publicly Released: May 17, 1990.
Additional Materials:
- Full Report:
Contact:
GAO discussed the U.S. government's role in helping the export of tobacco and tobacco products and the health-related implications of those activities. GAO found that: (1) the United States has a growing trade surplus in tobacco and tobacco products; (2) U.S. trade officials said that tobacco was legally sold in the United States and abroad and should be treated no differently than other products; (3) the U.S. trade representative did not appear to give preferential treatment to tobacco products over other items; (4) despite some difficulties in removing foreign barriers to U.S tobacco exports, there seemed to be no long-term adverse implications for U.S relations with four targeted countries; (5) the U.S. Surgeon General has determined that smoking is hazardous to health, and the U.S government actively works to discourage smoking, both domestically and internationally; (6) the Department of Health and Human Services (HHS) has the lead role in the U.S. government's smoking and health efforts; (7) the U.S. government supports international organizations' smoking prevention programs; (8) despite the government's anti-smoking efforts, health issues were not considered during negotiations for the removal of foreign trade barriers to U.S. tobacco exports; (9) HHS has been discouraged from activities that link health issues with U.S. tobacco exports; and (10) HHS perceives tobacco export issues as a trade matter.
Oct 26, 2020
-
Anesthesia Services:
Differences between Private and Medicare Payments Likely Due to Providers’ Strong Negotiating PositionGAO-21-41: Published: Oct 26, 2020. Publicly Released: Oct 26, 2020.
Oct 19, 2020
-
VA Health Care:
Better Data Needed to Assess the Health Outcomes of Lesbian, Gay, Bisexual, and Transgender VeteransGAO-21-69: Published: Oct 19, 2020. Publicly Released: Oct 19, 2020.
Oct 8, 2020
-
Laboratory Safety:
FDA Should Strengthen Efforts to Provide Effective OversightGAO-20-594: Published: Sep 8, 2020. Publicly Released: Oct 8, 2020.
Oct 1, 2020
-
Prescription Drug Monitoring Programs:
Views on Usefulness and Challenges of ProgramsGAO-21-22: Published: Oct 1, 2020. Publicly Released: Oct 1, 2020.
Sep 30, 2020
-
VA Acquisition Management:
Actions Needed to Improve Management of Medical-Surgical Prime Vendor Program and Inform Future DecisionsGAO-20-487: Published: Sep 30, 2020. Publicly Released: Sep 30, 2020.
Sep 23, 2020
-
VA Vet Centers:
Evaluations Needed of Expectations for Counselor Productivity and Centers' StaffingGAO-20-652: Published: Sep 23, 2020. Publicly Released: Sep 23, 2020.
Sep 21, 2020
-
COVID-19:
Federal Efforts Could Be Strengthened by Timely and Concerted ActionsGAO-20-701: Published: Sep 21, 2020. Publicly Released: Sep 21, 2020.
Sep 17, 2020
-
Defense Health Care:
Implementation of Value-Based Initiatives in TRICAREGAO-20-695R: Published: Sep 17, 2020. Publicly Released: Sep 17, 2020.
Sep 16, 2020
-
Private Health Coverage:
Results of Covert Testing for Selected OfferingsGAO-20-634R: Published: Aug 24, 2020. Publicly Released: Sep 16, 2020.
Sep 14, 2020
-
Public Health Preparedness:
Information on the Use of Medical Reserve Corps Volunteers during EmergenciesGAO-20-630: Published: Sep 14, 2020. Publicly Released: Sep 14, 2020.
Looking for more? Browse all our products here

Explore our Key Issues on Health Care